Isoniazid Mylan 300 mg Tablets
PDF Leaflet Revision Date: 18 October 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Prophylaxis and treatment of tuberculosis.
Dosage (summary)
300 mg once daily for adults; not suitable for children.
Special Populations
- Hepatic impairment
- Renal impairment
- Diabetes mellitus
- Elderly
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- Increased risk of hepatotoxicity with alcohol
- Increased plasma levels of carbamazepine
- Increased risk of bleeding with warfarin
Contraindications
- Hypersensitivity to isoniazid
- Active liver disease
- Severe renal failure
- Seizure disorder
Common side effects
- Hepatitis
- Peripheral neuropathy
- Nausea
- Fatigue
Counselling Points
- Take on an empty stomach
- Avoid alcohol
- Report signs of liver damage immediately
Serious warnings
- Risk of severe hepatitis
- Monitor liver function regularly
- Caution in patients with a history of liver injury
Important Disclaimer
The Isoniazid Mylan 300 mg Tablets professional information leaflet below is the property of Viatris Healthcare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
